Barbara Drobits
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Psoriasis: Treatment and Pathogenesis
- Immune Response and Inflammation
- interferon and immune responses
- T-cell and B-cell Immunology
-
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Immunotherapy and Immune Responses 5
- Psoriasis: Treatment and Pathogenesis 2
- Immune Response and Inflammation 1
-
- Lymphoma Diagnosis and Treatment 1
- Co-authors
- Maria Sibilia (7 shared papers)Martin Holcmann (7 shared papers)Nicole Amberg (3 shared papers)Martina Hammer (1 shared paper)Marco Colonna (1 shared paper)Melissa K. Swiecki (1 shared paper)Erwin Friedrich Wagner (3 shared papers)Patrick Manfred Brunner (2 shared papers)
- Journals
- PLoS Pathogens (2 papers)EMBO Molecular Medicine (2 papers)Journal of Clinical Investigation (1 paper)Clinical Cancer Research (1 paper)Oncotarget (1 paper)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Barbara Drobits
11 papers receiving 732 citations
Peers
Comparison fields: 5 of 61
- Immunology 455
- Oncology 106
- Dermatology 23
- Epidemiology 39
- Molecular Biology 74
Countries citing papers authored by Barbara Drobits
This map shows the geographic impact of Barbara Drobits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Drobits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Drobits more than expected).
Fields of papers citing papers by Barbara Drobits
This network shows the impact of papers produced by Barbara Drobits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Drobits. The network helps show where Barbara Drobits may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Drobits, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 255 | |
| 2 | 2011 | 108 | |
| 3 | 2014 | 105 | |
| 4 | 2020 | 83 | |
| 5 | 2021 | 69 | |
| 6 | 2021 | 36 | |
| 7 | 2020 | 27 | |
| 8 | 2012 | 24 | |
| 9 | 2021 | 17 | |
| 10 | 2009 | 16 | |
| 11 | 2014 | 1 | |
| 12 | 2024 | 1 |
About Barbara Drobits
Barbara Drobits is a scholar working on Immunology, Pathology and Forensic Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 12 papers that have together received 742 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Immune Response and Inflammation (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Cell death mechanisms and regulation (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Immunology (455 citations), Oncology (106 citations), Dermatology (23 citations), Epidemiology (39 citations) and Molecular Biology (74 citations). Barbara Drobits has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Maria Sibilia, Martin Holcmann, Nicole Amberg, Martina Hammer, Marco Colonna, Melissa K. Swiecki, Erwin Friedrich Wagner, Patrick Manfred Brunner, Georg Stingl and Sylvia Knapp. Their work appears in journals such as PLoS Pathogens, EMBO Molecular Medicine, Journal of Clinical Investigation, Clinical Cancer Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.